ABLE: a new and improved amphotericin B for visceral leishmaniasis?
Berman
Jonathan
J
D000666:Amphotericin B / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D004334:Drug Administration Schedule; D004655:Emulsions / Q000737:chemistry; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008055:Lipids / Q000737:chemistry
D000981:Antiprotozoal Agents; D004655:Emulsions; D008055:Lipids; D000666:Amphotericin B